Osaic Holdings’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
RI
LCM
RG
BBA
Osaic Holdings's STOK Position: Q2 2026 in Review
Osaic Holdings increased its Stoke Therapeutics (STOK) stake by 20% in Q2 2026, buying an estimated $67.4K and bringing the position to 12,412 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #3836.
Osaic Holdings first reported a position in STOK in Q3 2020 and has held it in 22 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.
- Osaic Holdings held 12,412 shares of Stoke Therapeutics worth $406K as of Q2 2026.
- Osaic Holdings bought 2,100 Stoke Therapeutics shares in Q2 2026, an estimated $67.4K.
- Stoke Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3836 holding.
- Osaic Holdings first reported a position in Stoke Therapeutics in Q3 2020 and has held it in 22 quarters since.
- 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.